Israeli's anti-coronavirus nasal spray '99.9 per cent' effective in lab test

A company co-founded by an Israeli has come up with a nasal spray that has been shown to be highly effective at killing coronavirus in the upper airways, before the infection can spread to the rest of the body.

The Nitric Oxide Nasal Spray, developed by Canadian company SaNOtize, proved 99.9 per cent effective in independent lab tests in the US, at Utah State University’s Antiviral Research Institute. It is currently undergoing Phase II clinical trials throughout Canada.

UK trials of the spray will begin on January 11 at Ashford and St Peter’s Hospitals NHS Foundation Trust in Surrey.

SaNOtize was co-founded by Canada-based Israeli Dr Gilly Regev, now the CEO of the company. Dr Regev was raised in Israel and has a PhD in Biochemistry from the Hebrew University.